Gestational Age-Specific Cutoff Levels of TDx-FLM II for the Prediction of Neonatal Respiratory Distress Syndrome

被引：4

作者：

Bennasar, Mar ^{[2
]}

Figueras, Francesc ^{[2
]}

Palacio, Montse ^{[2
]}

Bellart, Jordi ^{[2
]}

Casals, Elena ^{[1
]}

Figueras, Josep ^{[3
]}

Coll, Oriol ^{[2
]}

Gratacos, Eduard ^{[2
]}

机构：

[1] Univ Barcelona, Hosp Clin, Inst Invest Biomed Augusto Pi & Sunyer, Dept Biochem, ES-08028 Barcelona, Spain

[2] Univ Barcelona, Hosp Clin, Inst Invest Biomed Augusto Pi & Sunyer, Maternal Fetal Med Dept, ES-08028 Barcelona, Spain

[3] Univ Barcelona, Hosp Clin, Inst Invest Biomed Augusto Pi & Sunyer, Inst Clin Ginecol Obstet & Neonatol,Dept Neonatol, ES-08028 Barcelona, Spain

来源：

FETAL DIAGNOSIS AND THERAPY | 2009年 / 25卷 / 04期

关键词：

Fetal lung maturity; Gestational age; Respiratory distress syndrome; TDx fetal lung maturity assay; FETAL LUNG MATURITY; TO-ALBUMIN RATIO; AMNIOTIC-FLUID; FLUORESCENCE POLARIZATION; ASSAY; PHOSPHATIDYLCHOLINE; PHOSPHOLIPIDS; ACCURACY; DISEASE;

D O I：

10.1159/000236152

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Aim: To construct a predictive model for respiratory distress syndrome (RDS) from gestational age (GA) at delivery and TDx-FLM II value. Methods: Pregnant women who underwent an amniocentesis in which TDx-FLM II was determined were included in the study. A model for the occurrence of RDS was constructed by means of a logistic regression procedure from TDx-FLM II values and GA at delivery. Results: The mean value of TDx-FLM II was 47.11 mg/g. The mean GA at delivery was 33.4 weeks. The incidence of RDS was 7.8% (18/231). The optimal cutoff of predicted risk for respiratory distress was found to be 8.8%, resulting in a sensitivity and specificity of 89 and 83%, respectively. Conclusions: The adjustment of the TDx-FLM II value for GA at delivery results in a significant improvement in the predictive capacity of the test for the occurrence of RDS. The use of GA-specific cutoff values may simplify clinical decisions. Copyright (C) 2009 S. Karger AG, Basel

引用

页码：392 / 396

页数：5

共 19 条

[1] Prediction of risk for respiratory distress syndrome using gestational age and the TDx-FLM II assay
Gronowski, AM
Parvin, CA
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 189 (05) : 1511 - 1512
[2] Predicting risk of neonatal respiratory distress syndrome based on TDX-FLM and gestational age
Dola, C
Nelson, L
Clejan, S
Joycelyn
Kasavan, M
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 193 (06) : S139 - S139
[3] Using the TDx-FLM assay and gestational age together for more accurate prediction of risk for neonatal respiratory distress syndrome
Stubblefield, PG
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2002, 187 (06) : 1429 - 1430
[4] A COMPARISON OF THE ACCURACY OF THE TDX-FLM ASSAY, LECITHIN-SPHINGOMYELIN RATIO, AND PHOSPHATIDYLGLYCEROL IN THE PREDICTION OF NEONATAL RESPIRATORY-DISTRESS SYNDROME
HAGEN, E
LINK, JC
ARIAS, F
OBSTETRICS AND GYNECOLOGY, 1993, 82 (06): : 1004 - 1008
[5] Risk assessment for neonatal respiratory distress syndrome with FLM II combined with gestational age
Pinette, MG
Wax, J
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 193 (05) : 1879 - 1879
[6] The probability of neonatal respiratory distress syndrome as a function of gestational age and FLM S/A II value
Mcelrath, TF
Colon, I
Hecht, J
Tanasijevic, MJ
Norwitz, ER
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 189 (06) : S163 - S163
[7] Risk assessment for neonatal respiratory distress syndrome with FLM II combined with gestational age - Reply
Parvin, CA
Kaplan, LA
Chapman, JF
McManamon, TG
Gronowski, AM
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 193 (05) : 1880 - 1880
[8] Comparison of lamellar body counts with the TDx FLM II assay to assess risk for respiratory distress syndrome.
Luzzi, VI
Hankins, K
Gronowski, AM
CLINICAL CHEMISTRY, 2003, 49 (06) : A26 - A27
[9] Gestational age specific probability of respiratory distress syndrome.
Karcher, RE
Sykes, E
Shade, G
Hockman, E
Uddin, Z
CLINICAL CHEMISTRY, 2004, 50 (06) : A125 - A125
[10] Prediction of respiratory distress syndrome using the Abbott FLM-II amniotic fluid assay
Kaplan, LA
Chapman, JF
Bock, JL
Maria, ES
Clejan, S
Huddleston, DJ
Reed, RG
Bernstein, LH
Gillen-Goldstein, J
CLINICA CHIMICA ACTA, 2002, 326 (1-2) : 61 - 68

← 1 2 →